New drug R3R01 targets protein leak in tough kidney diseases
Disease control
Completed
This study tested a new drug, R3R01, in 43 people with Alport syndrome or a kidney condition called focal segmental glomerulosclerosis (FSGS) who still had protein in their urine despite standard treatment. The main goals were to check the drug's safety and see if it could reduce…
Phase: PHASE2 • Sponsor: River 3 Renal Corp. • Aim: Disease control
Last updated May 17, 2026 09:25 UTC